Evidence map›Paper›PMID 27374986›Full record

ReviewEpilepsia2016

WONOEP appraisal: Molecular and cellular biomarkers for epilepsy.

Lauren E Walker, Damir Janigro, Uwe Heinemann, Raili Riikonen, Christophe Bernard, Manisha Patel

Open access · greenAbstract readReview
In one paragraph

Review in Epilepsia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Clinical and biochemical assessments of circulating High Mobility Group Box Protein1 in children with epilepsy: relation to cognitive function and drug responsiveness.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. LiqBioer: a manually curated database of cancer biomarkers in body fluid.Database : the journal of biological databases and curation · 2022
    Article
  13. Is there a place for cellular therapy in depression?World journal of psychiatry · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Impact of Stress on Epilepsy: Focus on Neuroinflammation-A Mini Review.International journal of molecular sciences · 2021
    Review
  18. Article
  19. Review
  20. Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers.Journal of neuropathology and experimental neurology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Lauren E WalkerWolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, United Kingdom.
Damir JanigroFlocel, Inc., Case Western Reserve University Cleveland, Cleveland, Ohio, U.S.A.
Uwe HeinemannNeuroscience Research Center Charité, Berlin, Germany.
Raili RiikonenUniversity of Kuopio, University of Eastern Finland, Kuopio, Finland.
Christophe BernardAix-Marseille University, Inserm, INS UMR_S 1106, Marseille, France.
Manisha PatelDepartment of Pharmaceutical Science, University of Colorado, Aurora, Colorado, U.S.A.
Charité - Universitätsmedizin Berlin · DEInserm · FRUniversity of Eastern Finland · FIUniversity of Liverpool · GB

Funding

SUPEROXIDE RADICALS IN SEIZURE-INDUCED NEURONAL DEATHR01NS039587 · NINDS · UNIVERSITY OF COLORADO DENVER · PI PATEL, MANISHA N · 2000 to 2019
$5.9M
Redox Control of Seizure-Induced Neuroinflammation.R01NS086423 · NINDS · UNIVERSITY OF COLORADO DENVER · PI PATEL, MANISHA N · 2013 to 2022
$3.0M
Medical Research Council G1000417NINDS NIH HHS R01 NS039587NINDS NIH HHS R01 NS086423
6 · The paper itself

Abstract

Peripheral biomarkers have myriad potential uses for treatment, prediction, prognostication, and pharmacovigilance in epilepsy. To date, no single peripheral biomarker has demonstrated proven effectiveness, although multiple candidates are in development. In this review, we discuss the major areas of focus including inflammation, blood-brain barrier dysfunction, redox alterations, metabolism, hormones and growth factors.

Indexed as

AnimalsBiomarkersBlood-Brain BarrierEpilepsyHumansInflammationIntercellular Signaling Peptides and ProteinsBiomarkersIntercellular Signaling Peptides and ProteinsBlood-brain barrierbrain derived neurotrophic factorHigh mobility group box 1 (HMGB1)InflammationInsulin-like growth factorS100B

Identifiers

PMID27374986
PMCPMC5515385
OpenAlexW2472139699

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.